Literature DB >> 30914149

Cytogenetic Biomarkers of Radiation Exposure.

R M Anderson1.   

Abstract

Biological monitoring of radiation exposure relies heavily on the quantification of chromosome aberrations such as dicentrics and reciprocal translocations in the peripheral blood lymphocytes of exposed and potentially exposed subjects. The differences in the spatial deposition of energy and the quality of damage initially induced between individual low- and high-linear energy transfer (LET) radiation tracks are known to impact dramatically on the type and complexity of chromosome aberration induced. Over the years, researchers have proposed numerous cytogenetic markers and signatures based on these differences with the aim of biologically discriminating exposure to radiation of varying qualities. Complex chromosome aberrations are a broad classification of aberration types that are known to be characteristically induced after low doses of high-LET. The mechanistic basis for complex aberration formation and the potential applicability of these complex aberration products as LET-specific biomarkers are considered.
Copyright © 2019 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Keywords:  Chromosomal biomarker; Chromosomal signature; Complex chromosome aberrations; High-LET; Radiation exposure

Year:  2019        PMID: 30914149     DOI: 10.1016/j.clon.2019.02.009

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  2 in total

1.  Comparative metabolic profiles of total and partial body radiation exposure in mice using an untargeted metabolomics approach.

Authors:  Kiran Maan; Ritu Tyagi; Ajaswrata Dutta; Radhika Bakhshi; Poonam Rana
Journal:  Metabolomics       Date:  2020-11-27       Impact factor: 4.290

Review 2.  Chromatin and the Cellular Response to Particle Radiation-Induced Oxidative and Clustered DNA Damage.

Authors:  John M Danforth; Luc Provencher; Aaron A Goodarzi
Journal:  Front Cell Dev Biol       Date:  2022-07-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.